The new appropriation bill was recently signed into law by President Trump, which contained a $350 million increase for dementia and Alzheimer’s research funding at the National Institute of Health. This particular increase has brought the national funding for NIH research into dementia and Alzheimer’s to $2.8 billion.
According to the Executive Director of Alzheimer’s Impact Movement and the Alzheimer’s Association Chief Public Policy, Robert Egge, the funds are being used to create the groundwork for breakthroughs that will help those who have been affected by this disease.
AIM and the Alzheimer’s Association credit Representatives Rosa DeLauro of Connecticut and Tom Cole of Oklahoma as well as Senators Patty Murray of Washington and Roy Blunt of Missouri as being a huge part of securing this historic increase.
Egge goes on to state that they are thankful for the dedicated advocates who have driven Congress to act on this bill fully and for the bipartisan champions who understand just how important NIH and medical research is.
This appropriation bill also has a $10 million portion that will be used to create Building Our Largest Dementia or BOLD Infrastructure for Alzheimer’s Act. This passed in 2018, and the law states that the CDC is to strengthen the public health infrastructure all over the United States by creating Alzheimer’s interventions that are focused on public health problems like increasing early diagnosis and detection, preventing avoidable hospitalization, and reducing the risk. It also helped to establish Related Dementias and Alzheimer’s Public Health Centers of Excellence by providing funding to tribal, local, and state public health departments as well as increasing timely reporting and data analysis.
The bill, which is one of two appropriation measures that was passed by Congress and then signed by President Trump, authorizes the bills to fund the operations of certain agencies within the federal government until September of 2020.
Dementia happens to be the most expensive disease within the United States, according to AIM and the Alzheimer’s Association. It costs taxpayers in 2019 around $290 billion, and it affected more than 5 million people in the United States and 16 million unpaid caregivers of those who have dementia or Alzheimer’s.
To grow your business in the senior industry, Create a free profile on Senior GuidePost. The Industry’s premium resource for Senior communities to find Qualified vendors serving the Senior Industry